You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a ...

This ASX tech stock has delivered enormous returns in the past year. A leading fund manager thinks it can still deliver more ...

Three S&P/ASX 200 Index (ASX: XJO) healthcare stocks are well placed to outperform in 2025. Here’s what you need to know.

Knowing when to sell shares is more difficult than you might first think. Plenty of mistakes are made. Let's see when it's ...

Over the course of the 12 months, Zip's shares rallied a massive 363%. This made it the best performing stock on the ASX 200 ...

ASX exchange-traded funds (ETFs) continue to grow in popularity on the Australian share market. Here are some of the most ...

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through ...

Telstra Group Ltd (ASX: TLS) shares are in the red today despite the telco giant signing a deal with Elon Musk's ...

The first full trading week of 2025 is ending on a high note for stockholders of two rocketing ASX small-cap shares. Here’s ...

The Novonix share price is now up approximately 15% since this time last year. Though, it remains down heavily on a two-year ...

These two S&P/ASX 300 Index (ASX: XKO) shares are highly rated by a leading fund manager. Here’s why these experts are ...